for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Idorsia: Positive Results In Second Phase 3 Study Of Daridorexant

July 6 (Reuters) - IDORSIA LTD:

* ANNOUNCES POSITIVE RESULTS IN SECOND PHASE 3 STUDY OF DARIDOREXANT

* RESULTS CONFIRM AND REINFORCE EFFICACY AND SAFETY PROFILE FROM FIRST PIVOTAL STUDY

* COMPANY TARGETS FILING NEW DRUG APPLICATION (NDA) AROUND END OF 2020 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up